UK Launches £22M AI Hub to End Animal Testing
New Cambridge hub uses AI and organoids to accelerate drug discovery and move research away from animal models.
A scientist in a modern laboratory monitors a digital display and 3D organoid models, representing the UK's new initiative to replace animal testing with AI and human tissue.
Photo: Kronos News
UK Science Minister Chris McDonald announced a £22 million investment to shift research away from animal testing [1]. The initiative funds nine high-tech projects using AI to predict how drugs behave in humans [1]. This move aims to provide patients with faster access to new medicines [1].
A central part of the plan is the Pre-clinical Translational Models Hub in Cambridge [1]. This facility will develop "organoids," which are lab-grown human tissues that mimic real organs [1]. Researchers expect these models to provide more accurate data than traditional animal studies [1].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Risk level elevated to high because the story relies on a single primary source (GOV.UK), failing the recommendation for three independent domains.
Sources
Related stories
View allAbout the author
Kronos News Desk covers news and editorial analysis for Kronos News.
